COVID-19 Action Initiative

Funding Agency:
American Lung Association

The American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics.

The COVID-19 Action Initiative will be used to:

  • Expand the Lung Association’s ongoing respiratory research program

  • Enhance key public health measures through education and advocacy
  • Establish an advanced network to stop future respiratory virus pandemics

There is an urgent need to better understand the pathobiology and clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19, as well as increase knowledge about the potential emerging threat of other novel respiratory viruses. We are looking for proposals to advance research against emerging respiratory pathogens like SARS-CoV-2. All research must directly be related to COVID-19 or other viral respiratory threats that may arise in the future.

Full RFP

Deadline: May 30, 2020

Agency Website

Eligibility Requirements

At the time of application, the applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space as evidenced by a Department Chair or equivalent letter) in a recognized academic or other not-for-profit research institution.



Amount Description

The American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award is for $100,000 per year, for up to two years. The award is intended to support independent investigators with a stellar track record of accomplishment, who have the potential to advance our knowledge of COVID-19 and other novel respiratory viruses with epidemic potential.

Funding Type



Junior Faculty


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 30, 2020